QT
CRDF icon

Quantbot Technologies’s Cardiff Oncology CRDF Stock Holding History

Quantbot Technologies’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,300
Closed -$2K – 1668
2022
Q2 		$2K Sell
1,300
-10,300
-89% -$17.3K ﹤0.01% 1625
2022
Q1 		$28K Buy
+11,600
New +$41K ﹤0.01% 1311
2015
Q4 		– Sell
-11
Closed -$4K – 1118
2015
Q3 		$4K Hold
11
– – ﹤0.01% 1123
2015
Q2 		$8K Buy
+11
New +$7.8K ﹤0.01% 1003

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Quantbot Technologies's CRDF Position: Q3 2022 in Review

Quantbot Technologies sold out of Cardiff Oncology (CRDF) in Q3 2022, closing a stake of 1,300 shares — an estimated $2K sold.

Quantbot Technologies first reported a position in CRDF in Q2 2015 and held it in 4 quarters. The position peaked at $28K in Q1 2022. 58 funds tracked by Wall St. Rank hold CRDF as of Q3 2022.

  • Quantbot Technologies reported no remaining Cardiff Oncology position as of Q3 2022 after selling out during the quarter.
  • Quantbot Technologies sold 1,300 Cardiff Oncology shares in Q3 2022, an estimated $2K.
  • Quantbot Technologies first reported a position in Cardiff Oncology in Q2 2015 and held it in 4 quarters.
  • Quantbot Technologies's Cardiff Oncology position peaked at $28K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.